Procurement Summary
Country: France
Summary: Evaluation of the Efficiency of the Spm001 Peptide in a Model of Dlbcl xenogreffe for the Needs of the Satt Axlr
Deadline: 01 Aug 2024
Other Information
Notice Type: Tender
TOT Ref.No.: 104347684
Document Ref. No.: 3883203
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
This market aims to carry out an evaluation of the efficiency of the PEPTIDE SPM001, in a model of xenogreffe DLBCL (broadcast Large B Cell lymphoma) by way, alone or in association with ibutrinib.the team aims to carry out an evaluation of the Efficacy of the Peptide SPM001, in A xenograft DLBCL (Diffuse Large B Cell Lymphoma) Model by Sc Route, Alone or in Combination with Ibutrinib.
lot (s):
Information panel on the various lots of the notice in 3 columns: lot number, titled and deadline for deposit. Lot number entitled
1, 3883203
Procedure type: Open adapted procedure
Market type: services
Date of Plus Presentation: August 1, 2024 12:00 (Paris time)
Documents
Tender Notice